BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25996644)

  • 1. The fate of pediatric prescriptions in community pharmacies.
    Condren ME; Desselle SP
    J Patient Saf; 2015 Jun; 11(2):79-88. PubMed ID: 25996644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keeping the "continuous" in continuous quality improvement: exploring perceived outcomes of CQI program use in community pharmacy.
    Boyle TA; Bishop AC; Duggan K; Reid C; Mahaffey T; MacKinnon NJ; Mahaffey A
    Res Social Adm Pharm; 2014; 10(1):45-57. PubMed ID: 23528447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of e-prescribing in chain community pharmacy: best-practice recommendations.
    Rupp MT; Warholak TL
    J Am Pharm Assoc (2003); 2008; 48(3):364-70. PubMed ID: 18595821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of multiple methods to measure impact of a centralized call center on academic health system community pharmacies.
    Nickman NA; Drews FA; Tyler LS; Kelly MP; Ragsdale RJ; Rim M
    Am J Health Syst Pharm; 2019 Feb; 76(6):353-359. PubMed ID: 31361842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of community chain pharmacists' interventions on electronic prescriptions.
    Warholak TL; Rupp MT
    J Am Pharm Assoc (2003); 2009; 49(1):59-64. PubMed ID: 19196598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions.
    Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels SA; Novak S
    J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basic study to establish medication safety culture with patient-commitment style in community pharmacy: An examination from meeting reports].
    Onda M; Okuda N; Kosaka N; Takahashi N; Matsuura M; Yamaguchi Y; Yamada R
    Yakugaku Zasshi; 2007 Dec; 127(12):2075-8. PubMed ID: 18057796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists' perspectives of the current status of pediatric asthma management in the U.S. community pharmacy setting.
    Elaro A; Bosnic-Anticevich S; Kraus K; Farris KB; Shah S; Armour C; Patel MR
    Int J Clin Pharm; 2017 Aug; 39(4):935-944. PubMed ID: 28497209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of electronic prescriptions on medication safety in Finnish community pharmacies: A survey of pharmacists.
    Kauppinen H; Ahonen R; Timonen J
    Int J Med Inform; 2017 Apr; 100():56-62. PubMed ID: 28241938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community pharmacists, medication monitoring, and the routine nature of refills: a qualitative study.
    Witry MJ; Doucette WR
    J Am Pharm Assoc (2003); 2014; 54(6):594-603. PubMed ID: 25322259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restructuring supervision and reconfiguration of skill mix in community pharmacy: Classification of perceived safety and risk.
    Bradley F; Willis SC; Noyce PR; Schafheutle EI
    Res Social Adm Pharm; 2016; 12(5):733-46. PubMed ID: 26642961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The decision-making processes of pharmacists in inland Australia--a pilot study.
    Madden ME; Ball PA
    Rural Remote Health; 2011; 11(2):1573. PubMed ID: 21534711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of pharmacists' interventions on electronic versus traditional prescriptions in 2 community pharmacies.
    Gilligan AM; Miller K; Mohney A; Montenegro C; Schwarz J; Warholak TL
    Res Social Adm Pharm; 2012; 8(6):523-32. PubMed ID: 22264963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-prescribing errors identified in a compounding pharmacy: a quality-improvement project.
    Reed-Kane D; Kittell K; Adkins J; Flocks S; Nguyen T
    Int J Pharm Compd; 2014; 18(1):83-6. PubMed ID: 24881345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacists require additional support to develop capacity in delivering alcohol-related health information to older adults.
    Dare J; Wilkinson C; Garlepp M; Lo J; Allsop S
    Int J Pharm Pract; 2017 Aug; 25(4):301-310. PubMed ID: 27766721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and facilitators to recovering from e-prescribing errors in community pharmacies.
    Odukoya OK; Stone JA; Chui MA
    J Am Pharm Assoc (2003); 2015; 55(1):52-8. PubMed ID: 25539495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric medication use experiences and patient counseling in community pharmacies: Perspectives of children and parents.
    Abraham O; Brothers A; Alexander DS; Carpenter DM
    J Am Pharm Assoc (2003); 2017; 57(1):38-46.e2. PubMed ID: 27843107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Audit of community pharmacists' prescribing interventions: Quality assessment of a newly reimbursed service.
    MacKeigan LD; Dolovich L; Petrovic B; MacCallum L; Bojarski EA; Pojskic N
    J Am Pharm Assoc (2003); 2018; 58(6):622-629. PubMed ID: 30190200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.